Polaryx Therapeutics, Inc. PLYX Other Expense Recapitalization Of Common Stock
Other Expense Recapitalization Of Common Stock at other companies
Other financials
Where this comes from
Reported directly by Polaryx Therapeutics, Inc. in its filing.
Tagged under the XBRL concept plyx:OtherExpenseRecapitalizationOfCommonStock.
The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Polaryx Therapeutics, Inc. 's other expense recapitalization of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Polaryx Therapeutics, Inc. 's other expense recapitalization of common stock?
- Polaryx Therapeutics, Inc. (PLYX) reported other expense recapitalization of common stock of $6.5M in Q4 2024.
- What does other expense recapitalization of common stock mean?
- This captures non-recurring expenses or adjustments related to the restructuring or recapitalization of common equity. It reflects costs associated with changing the capital structure rather than core business operations.